Speed skating greats Lee and Kodaira meet in Gangwon
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Retired speed skater Lee Sang-hwa, a two-time Olympic gold medalist, reunited with fellow speed skating great Nao Kodaira at the Gangwon 2024 Winter Youth Olympics on Monday.
Lee, who announced her retirement in 2019, is a member of the organizing committee for the Youth Olympics, which is taking place at many of the venues used for the senior games in 2018.
Lee was the first Asian woman to win gold in the women's 500-meter speed skating contest at the Olympics, claiming the title for Korea at the Vancouver Winter Games in 2010.
She set the standing world record in the event in 2013, finishing with 36.36 seconds at a World Cup in Salt Lake City, Utah. Lee went on to defend her gold medal at the Sochi Winter Olympics the next year, in 2014.
Lee took a break from speed skating to undergo treatment for multiple injuries, and Kodaira, competing for Japan, quickly rose to the top — besting Lee in the women's 500-meter race at the PyeongChang 2018 Winter Olympics in Korea.
But following that race, Kodaira comforted Lee, saying, "Good job, I'm proud of you." The two later received the Korea-Japan Friendship Award for their demonstration of friendship on the ice.
BY MARY YANG [mary.yang@joongang.co.kr]
Copyright © 코리아중앙데일리. 무단전재 및 재배포 금지.
- IU scraps 'Love wins' single title after online backlash
- Seoul to launch sales of unlimited transit pass next Tuesday
- Major supermarkets gain weekend trading freedom in gov't overhaul
- [EXCLUSIVE] Big Tech layoffs loom in Korea as furious workers revolt
- Temperatures to nosedive as big freeze's wintery grip tightens
- Yoshiki, G-Dragon Instagram post garners talk of possible collaboration
- OpenAI CEO Sam Altman will visit Korea to meet with Samsung, SK
- JYP's future uncertain as ITZY and NMIXX struggle to sell
- Gambling site suspects turned illegal proceeds into fast cars, fine art and fat stacks of cash
- [NEWS IN FOCUS] Watch out for 'biological missile drugs,' the next big thing in pharma